# China NMPA Drug Inspection - Anhui Guanghe Traditional Chinese Medicine Co., Ltd. - Bai Ziren

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/anhui-guanghe-traditional-chinese-medicine-co-ltd/5668bc24-2996-4a57-a85b-d497f92e554e/
Source feed: China

> China NMPA drug inspection for Anhui Guanghe Traditional Chinese Medicine Co., Ltd. published October 29, 2020. Drug: Bai Ziren. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement of the Results of the Fourth Guangxi Drug Quality Spot Check in 2020 (No. 11 of 2020)
- Company Name: Anhui Guanghe Traditional Chinese Medicine Co., Ltd.
- Publication Date: 2020-10-29
- Drug Name: Bai Ziren
- Inspection Finding: Non-compliant with regulations; aflatoxin
- Action Taken: Relevant regulatory authorities have taken control measures against non-compliant products and are investigating and punishing them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/anhui-guanghe-traditional-chinese-medicine-co-ltd/f0558122-5599-494d-a3e7-a7671faaedd4/